SCLN Financial Facts
General and administrative: 7.9MBasic net income per share: 0.2
See Full Income Statement
Accrued and other current liabilities: 19.88M
Accumulated other comprehensive income: 1.36M
See Full Balance Sheet
SciClone Pharmaceuticals, Inc. (SCLN) Earnings
|
Expand Research on SCLN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +203.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/10/17 |  |
Q117 | $0.31 | $0.14 | +$0.17 | $42.9M | $39.94M | = |  | | Details |
3/6/17  |
|
Q416 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| 11/9/16 |
|
Q316 | $0.24 | N/A | N/A | $40.5M | $42.9M | N/A | | | Details |
| 8/9/16 |
|
Q216 | $0.20 | N/A | N/A | $39M | $37.9M | N/A | | | Details |
| 5/10/16 |
|
Q116 | $0.19 | N/A | N/A | $36.5M | $33.6M | N/A | | | Details |
| 3/10/16 |
|
Q415 | $0.30 | N/A | N/A | $42.9M | $41.1M | N/A | | | Details |
| 11/9/15 |
|
Q315 | $0.23 | N/A | N/A | $42.9M | $34.3M | N/A | | | Details |
| 8/10/15 |
|
Q215 | $0.26 | $0.12 | +$0.14 | $37.9M | $37.27M | N/A | | | Details |
